JPMORGAN CHASE & CO - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 81 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 2.36 and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$179
+188.7%
93
+116.3%
0.00%
Q2 2023$62430.0%0.00%
Q1 2023$0430.0%0.00%
Q4 2022$0430.0%0.00%
Q3 2022$0430.0%0.00%
Q2 2022$0430.0%0.00%
Q1 2022$0430.0%0.00%
Q4 2021$0430.0%0.00%
Q3 2021$0430.0%0.00%
Q2 2021$0
-100.0%
43
-100.0%
0.00%
Q1 2021$218,000
-6.0%
100,555
-3.0%
0.00%
Q4 2020$232,000
+222.2%
103,713
+378.5%
0.00%
Q3 2020$72,000
-15.3%
21,674
-22.6%
0.00%
Q2 2020$85,000
+7.6%
28,011
-31.0%
0.00%
Q1 2020$79,000
+107.9%
40,599
+209.2%
0.00%
Q4 2019$38,000
-20.8%
13,1320.0%0.00%
Q3 2019$48,000
+17.1%
13,132
+29.6%
0.00%
Q2 2019$41,000
-95.7%
10,136
-94.6%
0.00%
Q1 2019$964,000
+484.2%
188,691
+1656.1%
0.00%
Q1 2014$165,00010,7450.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 184,742$565,0000.18%
D.A. DAVIDSON & CO. 851,101$2,604,0000.05%
Iron Gate Global Advisors LLC 17,090$52,0000.02%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$37,0000.02%
IHT Wealth Management, LLC 28,155$86,0000.01%
OSAIC HOLDINGS, INC. 1,012,430$3,098,0000.01%
Ameritas Investment Company, LLC 10,782$33,0000.01%
Vivaldi Capital Management LP 15,439$40,0000.01%
CENTAURUS FINANCIAL, INC. 15,614$48,0000.01%
Geneos Wealth Management Inc. 37,017$108,0000.01%
View complete list of GALECTIN THERAPEUTICS INC shareholders